| Identification | Back Directory | [Name]
4-[4-(N-(3-chloro-(2R)-2-hydroxy-1-propyl)aMino)phenyl]Morpholin-3-one | [CAS]
1252018-10-2 | [Synonyms]
(R)-4-[4-[(3-Chloro-2-hydroxypropyl)amino]phenyl]morpholin-3-one
4-[4-(N-(3-chloro-(2R)-2-hydroxy-1-propyl)aMino)phenyl]Morpholin-3-one
4-[4-(N-(3-chloro-(2R)-2-hydroxy-1-p ropyl)amino)phenyl]morpholin-3-one 2-[(2R)-2-hydroxy-3-{[4-(3-oxomorph olin-4-yl)phenyl]amino}propyl]-1H-is oindole-1,3(2H)-dione 2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpho linyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1 | [Molecular Formula]
C13H17ClN2O3 | [MDL Number]
MFCD26386752 | [MOL File]
1252018-10-2.mol | [Molecular Weight]
284.739 |
| Hazard Information | Back Directory | [Uses]
4-[4-[[(2R)-3-Chloro-2-hydroxypropyl]amino]phenyl]-3-morpholinone (Rivaroxaban Impurity E) is an impurity of Rivaroxaban (R538000), which is a antithrombotic agent and a FXa inhibitor. |
|
| Company Name: |
Vercali Pharma
|
| Tel: |
9603199909 |
| Website: |
www.vercalipharma.com |
|